Source,Relation,Target
BIOTECH_TRIAL:NCT02644369,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02644369,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT02644369,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02644369,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02644369,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03225365,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03225365,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03225365,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03225365,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05654623,USES_DRUG_TYPE,HORMONAL
BIOTECH_TRIAL:NCT05654623,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05654623,HAS_DRUG_CLASS,Hormonal therapy
BIOTECH_TRIAL:NCT02955394,USES_DRUG_TYPE,HORMONAL
BIOTECH_TRIAL:NCT02955394,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02955394,HAS_DRUG_CLASS,Hormonal therapy
BIOTECH_TRIAL:NCT02162719,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02162719,TARGETS_BIOMARKER,AKT
BIOTECH_TRIAL:NCT02162719,TARGETS_BIOMARKER,PTEN
BIOTECH_TRIAL:NCT02162719,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02162719,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT05714553,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05714553,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05714553,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05714553,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02662725,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02662725,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02662725,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06612203,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06612203,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06612203,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04485013,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04485013,TARGETS_BIOMARKER,EGFR
BIOTECH_TRIAL:NCT04485013,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04485013,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03170960,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03170960,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03170960,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03170960,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03186937,USES_DRUG_TYPE,CELLULAR
BIOTECH_TRIAL:NCT03186937,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05181462,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT05181462,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05181462,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01977651,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT01977651,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06022029,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT06022029,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05274451,USES_DRUG_TYPE,CELLULAR
BIOTECH_TRIAL:NCT05274451,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05209529,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05209529,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05209529,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT05209529,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06797635,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06797635,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06797635,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06797635,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04243616,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04243616,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04243616,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05230186,USES_DRUG_TYPE,CELLULAR
BIOTECH_TRIAL:NCT05230186,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05230186,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT04149275,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04149275,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04149275,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04149275,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02419495,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT02419495,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01530984,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01530984,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01530984,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01750983,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01750983,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01750983,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04750382,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04750382,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01740297,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01740297,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01740297,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04508803,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04508803,TARGETS_BIOMARKER,BRCA1
BIOTECH_TRIAL:NCT04508803,TARGETS_BIOMARKER,PARP
BIOTECH_TRIAL:NCT04508803,TARGETS_BIOMARKER,PTEN
BIOTECH_TRIAL:NCT04508803,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04508803,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT04508803,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT02734290,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02734290,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02734290,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03336983,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT06920810,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06920810,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06920810,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT06920810,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06920810,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05057013,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05057013,TARGETS_BIOMARKER,HER3
BIOTECH_TRIAL:NCT05057013,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04024800,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT04024800,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04024800,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04024800,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02039674,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02039674,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02039674,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02039674,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06231693,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06231693,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03953235,USES_DRUG_TYPE,VACCINE
BIOTECH_TRIAL:NCT03953235,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03953235,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT01071564,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT01071564,INVOLVES_PATHWAY,Notch
BIOTECH_TRIAL:NCT01623349,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT01623349,TARGETS_BIOMARKER,PARP
BIOTECH_TRIAL:NCT01623349,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01623349,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT01623349,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT01676753,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01676753,TARGETS_BIOMARKER,MYC
BIOTECH_TRIAL:NCT01676753,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT01676753,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02441517,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02441517,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02814968,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02814968,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05831553,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05831553,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT05831553,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05831553,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05831553,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03164993,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03164993,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03164993,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03164993,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03425292,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03425292,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03425292,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03425292,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04117087,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT04117087,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04117087,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04117087,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01145430,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT01145430,TARGETS_BIOMARKER,PARP
BIOTECH_TRIAL:NCT01145430,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03893955,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03893955,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03893955,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02116582,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02116582,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06700382,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT06700382,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04052555,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT04504916,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04504916,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04504916,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04179864,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT04179864,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05035407,USES_DRUG_TYPE,DNA
BIOTECH_TRIAL:NCT05035407,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05846789,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05846789,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05846789,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02286921,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02286921,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04914390,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04914390,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04914390,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04866810,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT04866810,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03464942,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03464942,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03464942,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03464942,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06690840,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06690840,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT06690840,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06690840,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06690840,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03305445,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03305445,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03305445,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03305445,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06627712,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT06627712,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04060342,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04060342,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01942837,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT01942837,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06078384,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06078384,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06078384,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06078384,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04418154,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT04418154,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04418154,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02254785,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02254785,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02411656,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02411656,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02411656,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02411656,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02425891,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02425891,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT02425891,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02425891,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02425891,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05742269,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05742269,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT05742269,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05742269,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05742269,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03821935,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03821935,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03821935,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02938442,USES_DRUG_TYPE,VACCINE
BIOTECH_TRIAL:NCT02938442,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02495974,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02090114,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02090114,TARGETS_BIOMARKER,PTEN
BIOTECH_TRIAL:NCT02090114,TARGETS_BIOMARKER,TP53
BIOTECH_TRIAL:NCT02090114,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02227082,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02227082,TARGETS_BIOMARKER,PARP
BIOTECH_TRIAL:NCT02227082,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02227082,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT04895709,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04895709,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04895709,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04895709,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05877859,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT05877859,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05877859,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05877859,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03449108,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT03449108,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01997333,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01997333,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01997333,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03979508,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT03979508,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03979508,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT03979508,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02294461,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02294461,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05806385,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT05806385,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04954599,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT04954599,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04954599,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT05134194,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05134194,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05134194,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT00528567,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT00528567,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT00528567,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02620280,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02620280,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02620280,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02620280,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02404441,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT02404441,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT02404441,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02404441,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT01069796,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01069796,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02536794,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02536794,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT02536794,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02536794,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05014776,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05014776,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05014776,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05014776,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02484404,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02484404,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02484404,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT02484404,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02593227,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT02593227,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02272855,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02272855,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06786026,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06786026,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05599685,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05599685,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT05599685,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05599685,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05599685,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05000294,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05000294,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT05000294,TARGETS_BIOMARKER,VEGF
BIOTECH_TRIAL:NCT05000294,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05000294,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT05000294,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05000294,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04291755,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04291755,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04291755,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04291755,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06629779,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT06629779,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05086692,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT05086692,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05086692,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT02819518,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02819518,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT02819518,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02819518,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02819518,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06052852,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06052852,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02203695,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02203695,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02648477,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02648477,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02648477,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02648477,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04090710,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04090710,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04090710,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04090710,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05341492,USES_DRUG_TYPE,CELLULAR
BIOTECH_TRIAL:NCT05341492,TARGETS_BIOMARKER,EGFR
BIOTECH_TRIAL:NCT05341492,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05582538,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05582538,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05582538,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02670109,USES_DRUG_TYPE,CELLULAR
BIOTECH_TRIAL:NCT02670109,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05451849,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05451849,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT05451849,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03922880,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03922880,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03922880,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03922880,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03337724,USES_DRUG_TYPE,HORMONAL
BIOTECH_TRIAL:NCT03337724,TARGETS_BIOMARKER,PIK3CA
BIOTECH_TRIAL:NCT03337724,TARGETS_BIOMARKER,AKT
BIOTECH_TRIAL:NCT03337724,TARGETS_BIOMARKER,PTEN
BIOTECH_TRIAL:NCT03337724,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03337724,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT04239040,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04239040,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04239040,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04239040,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02755272,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02755272,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02755272,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02755272,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04250818,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT04250818,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05905341,USES_DRUG_TYPE,HORMONAL
BIOTECH_TRIAL:NCT05905341,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05905341,TARGETS_BIOMARKER,CDK4
BIOTECH_TRIAL:NCT05905341,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT05905341,HAS_DRUG_CLASS,Hormonal therapy
BIOTECH_TRIAL:NCT01767454,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01767454,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01767454,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06410534,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06410534,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06410534,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT06410534,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06410534,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02239900,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02239900,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02239900,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01323517,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01323517,TARGETS_BIOMARKER,MYC
BIOTECH_TRIAL:NCT01323517,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01323517,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01663415,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT01663415,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04296942,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04296942,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04296942,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02784366,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT02784366,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05174832,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05174832,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT05174832,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05174832,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT05174832,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05174832,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01896869,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01896869,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01896869,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04084951,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04084951,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04084951,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT04084951,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04084951,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02071862,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT02071862,TARGETS_BIOMARKER,EGFR
BIOTECH_TRIAL:NCT02071862,TARGETS_BIOMARKER,MYC
BIOTECH_TRIAL:NCT02071862,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02071862,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT01194271,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01194271,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01194271,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04789668,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT04789668,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT01827111,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01827111,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01827111,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06926868,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06926868,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT06926868,TARGETS_BIOMARKER,EGFR
BIOTECH_TRIAL:NCT06926868,TARGETS_BIOMARKER,HER3
BIOTECH_TRIAL:NCT06926868,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06926868,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04335669,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04335669,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04335669,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04335669,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01641406,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01641406,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01641406,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05629429,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT05629429,TARGETS_BIOMARKER,BRCA1
BIOTECH_TRIAL:NCT05629429,TARGETS_BIOMARKER,PARP
BIOTECH_TRIAL:NCT05629429,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05629429,INVOLVES_PATHWAY,DNA repair
BIOTECH_TRIAL:NCT05629429,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT03199040,USES_DRUG_TYPE,DNA
BIOTECH_TRIAL:NCT03199040,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03199040,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03101280,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03101280,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03101280,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03101280,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06965361,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT06965361,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT06965361,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06965361,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT05491083,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05491083,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05491083,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05491083,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT07005583,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT07005583,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT07005583,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT06802757,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06802757,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06802757,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06802757,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02301988,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02301988,TARGETS_BIOMARKER,AKT
BIOTECH_TRIAL:NCT02301988,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02301988,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT05888831,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05888831,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05888831,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05888831,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05968690,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT05968690,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05968690,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT05968690,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05968690,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01936961,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05929768,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT05929768,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05929768,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05929768,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01307891,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01307891,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01307891,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05191017,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT00834678,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT01451632,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01451632,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04136470,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT04136470,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03925233,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03925233,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03645928,USES_DRUG_TYPE,CELLULAR
BIOTECH_TRIAL:NCT03645928,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT06347068,USES_DRUG_TYPE,CELLULAR
BIOTECH_TRIAL:NCT06347068,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06908928,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06318507,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06318507,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06318507,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06318507,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04086758,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04086758,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04086758,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02883062,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02883062,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02883062,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02883062,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01281150,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT01281150,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT07007780,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT07007780,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT07007780,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02689427,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02689427,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06519370,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06519370,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05910710,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05910710,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05910710,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05910710,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03997123,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT05035745,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT05035745,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05035745,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT03917381,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03917381,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03917381,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03917381,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03832621,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03832621,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03832621,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT03832621,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03832621,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02605863,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT00162123,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT00162123,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT00162123,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT00986609,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT02640534,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02640534,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03844256,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03844256,TARGETS_BIOMARKER,MYC
BIOTECH_TRIAL:NCT03844256,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03844256,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03844256,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05001347,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05001347,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05001347,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05001347,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT07000396,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT07000396,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT07000396,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03232593,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03232593,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03232593,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03232593,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05128734,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT05128734,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05128734,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT04879849,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04879849,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04879849,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04879849,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03067935,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03067935,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04059003,USES_DRUG_TYPE,HORMONAL
BIOTECH_TRIAL:NCT04059003,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03071406,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03071406,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03071406,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03071406,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05358639,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT05358639,TARGETS_BIOMARKER,BRCA1
BIOTECH_TRIAL:NCT05358639,TARGETS_BIOMARKER,BRCA2
BIOTECH_TRIAL:NCT05358639,TARGETS_BIOMARKER,PARP
BIOTECH_TRIAL:NCT05358639,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05358639,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT05914961,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT05914961,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05914961,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT04468061,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04468061,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT04468061,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04468061,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04468061,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04360941,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04360941,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04360941,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01409174,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT01409174,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01409174,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02091960,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02091960,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02091960,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06318897,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06318897,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06318897,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06318897,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04152057,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04152057,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04152057,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01650194,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT01990209,USES_DRUG_TYPE,HORMONAL
BIOTECH_TRIAL:NCT01990209,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05029999,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT05029999,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04711824,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04711824,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04711824,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT04711824,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06606730,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06606730,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06606730,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06606730,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02278887,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT02278887,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02278887,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05447702,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05447702,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05447702,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06229067,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06229067,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT06229067,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06229067,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02677896,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT07017673,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT07017673,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT07017673,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05541367,USES_DRUG_TYPE,HORMONAL
BIOTECH_TRIAL:NCT05541367,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03197389,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03197389,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT03197389,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03197389,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03197389,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06649331,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04770272,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04770272,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04770272,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04770272,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT00618657,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT00618657,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT00618657,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05300412,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT05300412,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06922318,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT06922318,TARGETS_BIOMARKER,MYC
BIOTECH_TRIAL:NCT06922318,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04133948,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04133948,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04133948,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04133948,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04771871,USES_DRUG_TYPE,RNA
BIOTECH_TRIAL:NCT04771871,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04260802,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04260802,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT04260802,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04260802,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05111067,USES_DRUG_TYPE,RNA
BIOTECH_TRIAL:NCT05111067,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03325127,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT03325127,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02627430,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT02627430,TARGETS_BIOMARKER,PARP
BIOTECH_TRIAL:NCT02627430,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02627430,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT02221999,USES_DRUG_TYPE,HORMONAL
BIOTECH_TRIAL:NCT02221999,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01431196,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01431196,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01431196,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02452008,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02452008,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03829501,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03829501,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT03829501,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03829501,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03829501,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06210438,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06210438,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06210438,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04319224,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04319224,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04319224,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02215096,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02215096,TARGETS_BIOMARKER,PTEN
BIOTECH_TRIAL:NCT02215096,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02215096,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT02978443,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02978443,TARGETS_BIOMARKER,AKT
BIOTECH_TRIAL:NCT02978443,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02978443,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02978443,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT02978443,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02511847,USES_DRUG_TYPE,RNA
BIOTECH_TRIAL:NCT02511847,TARGETS_BIOMARKER,EGFR
BIOTECH_TRIAL:NCT02511847,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06894771,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06894771,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06894771,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06894771,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02446405,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT03223155,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03223155,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03223155,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03223155,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03639948,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03639948,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03639948,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03639948,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05958199,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05958199,TARGETS_BIOMARKER,EGFR
BIOTECH_TRIAL:NCT05958199,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04741438,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04741438,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04741438,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04741438,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03098550,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03098550,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03098550,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03098550,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02413827,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02413827,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02413827,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05113966,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05113966,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05113966,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05255666,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05255666,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05255666,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05255666,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05081492,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05081492,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT04303741,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04303741,TARGETS_BIOMARKER,EGFR
BIOTECH_TRIAL:NCT04303741,TARGETS_BIOMARKER,VEGF
BIOTECH_TRIAL:NCT04303741,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04303741,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06735131,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT03330405,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03330405,TARGETS_BIOMARKER,PARP
BIOTECH_TRIAL:NCT03330405,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03330405,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT03330405,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03952325,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03952325,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT03952325,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03952325,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03952325,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02125357,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02125357,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04015622,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT04015622,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04837209,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04837209,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT04837209,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04837209,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT04837209,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02839954,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT02839954,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05180006,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05180006,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT05180006,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05180006,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05180006,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT00633464,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT00633464,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04913571,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04913571,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT04913571,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04913571,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04331067,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04331067,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04331067,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04331067,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04464967,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04464967,TARGETS_BIOMARKER,EGFR
BIOTECH_TRIAL:NCT04464967,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04464967,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT07028853,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT07028853,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03821454,USES_DRUG_TYPE,HORMONAL
BIOTECH_TRIAL:NCT03821454,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06551324,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT06551324,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02138799,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT02138799,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03297385,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT03297385,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03460782,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03460782,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02530489,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02530489,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02530489,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02530489,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05011188,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT05011188,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01288911,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT01288911,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04638751,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT04638751,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05809752,USES_DRUG_TYPE,CELLULAR
BIOTECH_TRIAL:NCT05809752,TARGETS_BIOMARKER,HER3
BIOTECH_TRIAL:NCT05809752,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02513472,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02513472,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02513472,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02513472,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06795503,USES_DRUG_TYPE,RNA
BIOTECH_TRIAL:NCT06795503,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01111825,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01111825,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01111825,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04986852,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04986852,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04986852,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04076059,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT04076059,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05670925,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05670925,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05670925,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03815890,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03815890,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03815890,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03815890,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05088057,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05088057,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05088057,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01461044,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01461044,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01461044,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02685059,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT02685059,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT02685059,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03639714,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03639714,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03639714,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT03639714,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03639714,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04095689,USES_DRUG_TYPE,DNA
BIOTECH_TRIAL:NCT04095689,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04095689,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04095689,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03692689,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03692689,TARGETS_BIOMARKER,EGFR
BIOTECH_TRIAL:NCT03692689,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01974765,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT01974765,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05076760,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05076760,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05076760,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05076760,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05203445,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05203445,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05203445,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT05203445,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05203445,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06349512,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06349512,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06349512,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06349512,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06096870,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06096870,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04334759,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04334759,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT04334759,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04334759,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04334759,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03098160,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03098160,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03098160,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02685306,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02685306,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02685306,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03371017,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03371017,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03371017,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03371017,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05812807,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05812807,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05812807,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05812807,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02876107,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02876107,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02876107,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03498716,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03498716,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT03498716,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03498716,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03498716,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03018405,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT03018405,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01502592,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01502592,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01502592,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05953168,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05953168,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05953168,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03332368,USES_DRUG_TYPE,HORMONAL
BIOTECH_TRIAL:NCT03332368,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03150056,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT03150056,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03150576,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT03150576,TARGETS_BIOMARKER,PARP
BIOTECH_TRIAL:NCT03150576,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03150576,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT06353997,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06353997,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06353997,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06353997,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02365805,USES_DRUG_TYPE,RNA
BIOTECH_TRIAL:NCT02365805,TARGETS_BIOMARKER,BRCA1
BIOTECH_TRIAL:NCT02365805,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02365805,INVOLVES_PATHWAY,DNA repair
BIOTECH_TRIAL:NCT03401385,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03401385,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03401385,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05968599,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT05968599,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05852691,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT05852691,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT05852691,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05852691,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05852691,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03367689,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT03367689,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03367689,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT04464174,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT04464174,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03045393,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03045393,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03045393,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04142931,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04142931,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04142931,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04861077,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT04861077,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05969184,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05969184,TARGETS_BIOMARKER,CDK4
BIOTECH_TRIAL:NCT05969184,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT05969184,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04758780,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04758780,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04758780,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03213041,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03213041,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03213041,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03213041,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06632405,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06632405,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06632405,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02183805,USES_DRUG_TYPE,CELLULAR
BIOTECH_TRIAL:NCT02183805,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03797326,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03797326,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03797326,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03797326,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT00930930,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT00930930,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT00930930,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT03243838,USES_DRUG_TYPE,HORMONAL
BIOTECH_TRIAL:NCT03243838,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05485766,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05485766,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05485766,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT05485766,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05485766,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06926920,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06926920,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06926920,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04345913,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT04345913,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06845319,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06845319,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06845319,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06845319,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04443348,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04443348,TARGETS_BIOMARKER,MYC
BIOTECH_TRIAL:NCT04443348,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04443348,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04443348,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05522491,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT05522491,TARGETS_BIOMARKER,BRCA1
BIOTECH_TRIAL:NCT05522491,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05522491,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT04584255,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04584255,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04584255,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT04584255,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT07046195,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT07046195,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT00203502,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT00203502,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT00203502,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04699630,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04699630,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06240195,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06240195,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06240195,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04690855,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04690855,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT04690855,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04690855,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT04690855,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04690855,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05746897,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05746897,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05746897,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05746897,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT00546156,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT00546156,TARGETS_BIOMARKER,MYC
BIOTECH_TRIAL:NCT00546156,TARGETS_BIOMARKER,VEGF
BIOTECH_TRIAL:NCT00546156,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT00546156,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03853707,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT03853707,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03853707,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03853707,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03620643,USES_DRUG_TYPE,HORMONAL
BIOTECH_TRIAL:NCT03620643,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03620643,HAS_DRUG_CLASS,Hormonal therapy
BIOTECH_TRIAL:NCT05340413,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT05340413,TARGETS_BIOMARKER,BRCA1
BIOTECH_TRIAL:NCT05340413,TARGETS_BIOMARKER,BRCA2
BIOTECH_TRIAL:NCT05340413,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05340413,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT07038369,USES_DRUG_TYPE,HORMONAL
BIOTECH_TRIAL:NCT07038369,TARGETS_BIOMARKER,AKT
BIOTECH_TRIAL:NCT07038369,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT07038369,HAS_DRUG_CLASS,Hormonal therapy
BIOTECH_TRIAL:NCT02374242,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02374242,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02374242,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02374242,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01975831,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01975831,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT01975831,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01975831,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01094184,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01094184,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01094184,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05215470,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05215470,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05215470,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05215470,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01597193,USES_DRUG_TYPE,HORMONAL
BIOTECH_TRIAL:NCT01597193,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01597193,HAS_DRUG_CLASS,Hormonal therapy
BIOTECH_TRIAL:NCT02527434,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02527434,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03517488,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03517488,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03517488,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05200143,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05200143,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT05200143,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05200143,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05200143,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03564691,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03564691,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03564691,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03564691,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06371807,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06371807,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06371807,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06371807,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06754904,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06754904,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06754904,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT06754904,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06754904,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03475953,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03475953,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05005403,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05005403,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05005403,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02981303,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02981303,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02981303,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02981303,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02309177,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02309177,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02309177,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02309177,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06224673,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06224673,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03390608,USES_DRUG_TYPE,HORMONAL
BIOTECH_TRIAL:NCT03390608,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06691594,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06691594,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06691594,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03818685,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03818685,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03818685,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05981326,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05981326,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05981326,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT05627960,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02264678,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02264678,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02264678,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT02264678,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02716272,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02716272,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02716272,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02833883,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT00733408,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT00733408,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT00733408,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02730130,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02730130,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02730130,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02730130,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05064280,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05064280,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05064280,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05064280,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05520138,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT05520138,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06409221,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT06409221,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02259114,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT02259114,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05269381,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT05269381,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05269381,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05269381,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04148937,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04148937,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04148937,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04148937,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06610097,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT06610097,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02432963,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02432963,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02432963,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02432963,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04925284,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04925284,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04925284,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04925284,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03483012,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03483012,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03483012,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03483012,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06910072,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06910072,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06910072,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01810016,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01810016,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01810016,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03122522,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03122522,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03122522,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03122522,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06702995,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT06702995,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03043599,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03043599,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03043599,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03043599,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01234402,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01234402,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01234402,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06636591,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06636591,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06636591,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04501523,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04501523,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04501523,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02210104,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02210104,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02210104,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05101096,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05101096,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05101096,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06955156,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06955156,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06955156,TARGETS_BIOMARKER,CDK4
BIOTECH_TRIAL:NCT06955156,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT02500901,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02500901,TARGETS_BIOMARKER,PARP
BIOTECH_TRIAL:NCT02500901,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02500901,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT02574455,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02574455,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02574455,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT00892736,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT00892736,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03095352,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03095352,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03095352,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03095352,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04140526,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04140526,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04140526,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04140526,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03000257,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03000257,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03000257,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05325866,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05325866,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05325866,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06435351,USES_DRUG_TYPE,VACCINE
BIOTECH_TRIAL:NCT04094519,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT04094519,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04602117,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04602117,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04602117,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05585034,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05585034,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05585034,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05585034,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03343613,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03343613,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT01105312,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT04577963,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04577963,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04577963,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05809895,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05809895,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05809895,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05809895,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01927627,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT01927627,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01194908,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01194908,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01194908,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01194908,HAS_DRUG_CLASS,Hormonal therapy
BIOTECH_TRIAL:NCT04159818,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04159818,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04159818,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT04159818,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04159818,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02067741,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT02067741,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05741164,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05741164,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05741164,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT05741164,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05741164,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06532812,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06532812,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06532812,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06532812,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02423603,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02423603,TARGETS_BIOMARKER,AKT
BIOTECH_TRIAL:NCT02423603,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02423603,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT03109080,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT03109080,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03109080,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT05007106,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05007106,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05007106,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05007106,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03569280,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT03569280,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02799745,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02799745,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05383170,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05383170,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05383170,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05383170,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03313323,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03313323,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03313323,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06793553,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06793553,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT06793553,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06793553,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06793553,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05438706,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05438706,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05438706,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04042753,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04042753,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04042753,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04042753,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02661100,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02661100,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02661100,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02307149,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02307149,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02307149,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04300556,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04300556,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04300556,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04802876,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04802876,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04802876,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05491694,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05491694,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05491694,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05318469,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05318469,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT05318469,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05318469,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05318469,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05581004,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05581004,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05581004,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05581004,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06731153,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT06731153,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05103917,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05103917,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05103917,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06604858,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06604858,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06604858,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06604858,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06246968,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06246968,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06246968,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06246968,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06954480,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06954480,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06954480,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT06954480,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05252390,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT05252390,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05252390,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT05453825,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05453825,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05453825,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02554812,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02554812,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02554812,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02244580,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02244580,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02244580,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01331525,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01331525,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01331525,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06692725,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06692725,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06692725,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01151449,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT01151449,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01151449,INVOLVES_PATHWAY,Notch
BIOTECH_TRIAL:NCT02658214,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02658214,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02658214,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04498793,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04498793,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04498793,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05862064,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05862064,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05862064,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03145961,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03145961,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03145961,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03145961,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03901469,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03901469,TARGETS_BIOMARKER,BRCA1
BIOTECH_TRIAL:NCT03901469,TARGETS_BIOMARKER,BRCA2
BIOTECH_TRIAL:NCT03901469,TARGETS_BIOMARKER,TROP2
BIOTECH_TRIAL:NCT03901469,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03901469,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT01654692,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01654692,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02936102,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT02936102,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT02936102,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02936102,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT05843292,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05843292,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05843292,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03729596,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03729596,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03729596,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03961698,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03961698,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03961698,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT03961698,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04739800,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT04739800,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT04739800,TARGETS_BIOMARKER,PARP
BIOTECH_TRIAL:NCT04739800,TARGETS_BIOMARKER,VEGF
BIOTECH_TRIAL:NCT04739800,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04739800,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT04739800,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05492123,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05492123,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05492123,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05492123,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04986423,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT04986423,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04958785,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04958785,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04958785,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06112379,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06112379,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06112379,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06112379,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05177796,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05177796,TARGETS_BIOMARKER,EGFR
BIOTECH_TRIAL:NCT05177796,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05177796,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05177796,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02608437,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02608437,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05169957,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05169957,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05169957,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05169957,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT00790010,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT00790010,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT00790010,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02676986,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02676986,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06371274,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06371274,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06371274,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03280563,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03280563,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT03280563,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03280563,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03280563,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT03280563,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03280563,HAS_DRUG_CLASS,Hormonal therapy
BIOTECH_TRIAL:NCT05216432,USES_DRUG_TYPE,HORMONAL
BIOTECH_TRIAL:NCT05216432,TARGETS_BIOMARKER,PIK3CA
BIOTECH_TRIAL:NCT05216432,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05216432,TARGETS_BIOMARKER,CDK4
BIOTECH_TRIAL:NCT05216432,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT05216432,HAS_DRUG_CLASS,Hormonal therapy
BIOTECH_TRIAL:NCT02499367,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02499367,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02499367,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02499367,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01846091,USES_DRUG_TYPE,VIRAL
BIOTECH_TRIAL:NCT01846091,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02957968,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02957968,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02957968,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT02957968,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02957968,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02681562,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02681562,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02681562,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT02682693,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02682693,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02682693,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06259162,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT06259162,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT03454451,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03454451,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03454451,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03454451,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04432857,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04432857,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04432857,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04432857,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02954874,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02954874,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02954874,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04787991,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04787991,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04787991,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04787991,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05650476,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT05650476,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05650476,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT02225093,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02225093,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03761914,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03761914,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03761914,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04445844,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04445844,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02064582,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT03487666,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03487666,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03487666,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT03487666,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03487666,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03289962,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03289962,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT03289962,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03289962,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03289962,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05954442,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT05954442,TARGETS_BIOMARKER,AKT
BIOTECH_TRIAL:NCT05954442,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05954442,INVOLVES_PATHWAY,PI3K/AKT
BIOTECH_TRIAL:NCT05954442,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT03849469,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03849469,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03849469,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03849469,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06823479,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06823479,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06823479,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06823479,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04890028,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT04890028,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03459222,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03459222,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03459222,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03459222,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03012100,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT03012100,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06027268,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06027268,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06027268,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06027268,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03792529,USES_DRUG_TYPE,HORMONAL
BIOTECH_TRIAL:NCT03792529,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03875313,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT03875313,TARGETS_BIOMARKER,PARP
BIOTECH_TRIAL:NCT03875313,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03875313,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT06841354,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06841354,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT06841354,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06841354,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06841354,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04427293,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04427293,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04427293,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04427293,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03620123,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03620123,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03620123,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03620123,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03801369,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT03801369,TARGETS_BIOMARKER,PARP
BIOTECH_TRIAL:NCT03801369,TARGETS_BIOMARKER,AKT
BIOTECH_TRIAL:NCT03801369,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03801369,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT03801369,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT03801369,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02385669,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT02385669,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02385669,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT00777673,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT00777673,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT00777673,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03110107,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03110107,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03110107,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05539365,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05539365,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT05539365,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05539365,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT05539365,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05539365,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05746728,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05746728,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05746728,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03387761,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03387761,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03387761,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03387761,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03872505,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03872505,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03872505,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02539017,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT02539017,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04683445,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT04683445,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05215106,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05215106,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05215106,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06700369,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06700369,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06700369,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05209243,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT05209243,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06774027,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06774027,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06157892,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06157892,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06157892,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06946797,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06946797,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06946797,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06946797,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06324240,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06324240,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06324240,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06324240,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03316586,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03316586,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03316586,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03316586,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01119508,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01119508,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01119508,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01009437,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT01009437,TARGETS_BIOMARKER,AKT
BIOTECH_TRIAL:NCT01009437,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01009437,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT04326257,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04326257,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT04326257,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04326257,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04326257,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03366844,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03366844,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03366844,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03366844,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05632848,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05632848,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05632848,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02732119,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02732119,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02732119,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT05139706,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT05139706,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05139706,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT03742349,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03742349,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03742349,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04787042,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04787042,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04787042,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04787042,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03616886,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT03616886,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT03616886,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03616886,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT03616886,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03674814,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT01590082,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01590082,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01590082,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05627752,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT05627752,TARGETS_BIOMARKER,PARP
BIOTECH_TRIAL:NCT05627752,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04230109,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04230109,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04230109,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04230109,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03289819,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03289819,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03289819,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03289819,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04981119,USES_DRUG_TYPE,CELLULAR
BIOTECH_TRIAL:NCT04981119,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06819319,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06819319,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06819319,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03777579,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03777579,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02743819,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02743819,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02743819,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02743819,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04916002,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04916002,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04916002,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06992336,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT06992336,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06134375,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06134375,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06134375,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06134375,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05112536,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT05112536,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03394287,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03394287,TARGETS_BIOMARKER,EGFR
BIOTECH_TRIAL:NCT03394287,TARGETS_BIOMARKER,VEGF
BIOTECH_TRIAL:NCT03394287,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02789332,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02789332,TARGETS_BIOMARKER,BRCA1
BIOTECH_TRIAL:NCT02789332,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02789332,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT02555657,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02555657,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02555657,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02555657,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01510288,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01510288,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03752398,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03752398,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03752398,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03106415,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT03106415,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03106415,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03106415,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06434064,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT06434064,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06434064,INVOLVES_PATHWAY,DNA repair
BIOTECH_TRIAL:NCT06434064,HAS_DRUG_CLASS,Hormonal therapy
BIOTECH_TRIAL:NCT03920566,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT03920566,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03519178,USES_DRUG_TYPE,HORMONAL
BIOTECH_TRIAL:NCT03519178,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03519178,HAS_DRUG_CLASS,Hormonal therapy
BIOTECH_TRIAL:NCT05368506,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT05368506,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05082259,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05082259,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05082259,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05082259,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01426880,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01426880,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01426880,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02138162,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02138162,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06110793,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06110793,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06110793,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06110793,HAS_DRUG_CLASS,Hormonal therapy
BIOTECH_TRIAL:NCT06407310,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06407310,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06407310,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06407310,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06103864,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06103864,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT06103864,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06103864,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06103864,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02941744,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02941744,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02941744,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02941744,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04105582,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT04105582,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03563729,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03563729,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03563729,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03563729,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03606967,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT03606967,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03606967,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05978648,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05978648,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05978648,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06351332,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06351332,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06351332,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06351332,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05329532,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05329532,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05329532,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05329532,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02960022,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02960022,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03544723,USES_DRUG_TYPE,DNA
BIOTECH_TRIAL:NCT03544723,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT03544723,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03544723,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT05645380,USES_DRUG_TYPE,CELLULAR
BIOTECH_TRIAL:NCT05645380,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04613674,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04613674,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04613674,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02750358,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02750358,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04085276,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04085276,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04085276,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01186991,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01186991,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01186991,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01216696,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01216696,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01216696,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03621982,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03621982,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03621982,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04892043,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT04892043,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04892043,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT05288127,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT05288127,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05288127,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT03977571,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03977571,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03977571,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT03977571,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03977571,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04821622,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT04821622,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04821622,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT04234113,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04234113,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04234113,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04234113,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05483491,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT05483491,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01349959,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT06349642,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT02898207,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT02898207,TARGETS_BIOMARKER,PARP
BIOTECH_TRIAL:NCT02898207,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02898207,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT04249167,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04249167,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT04249167,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04249167,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04249167,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01238133,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT01238133,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01575522,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT01575522,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03205761,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT03205761,TARGETS_BIOMARKER,BRCA1
BIOTECH_TRIAL:NCT03205761,TARGETS_BIOMARKER,BRCA2
BIOTECH_TRIAL:NCT03205761,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03205761,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT03175666,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03175666,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01804465,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01804465,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02616848,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02616848,TARGETS_BIOMARKER,MYC
BIOTECH_TRIAL:NCT02616848,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02616848,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT05756166,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT05756166,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05756166,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05756166,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01889238,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT01889238,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02834247,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02834247,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02834247,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02834247,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02322814,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02322814,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02322814,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02322814,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02456857,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT02456857,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02456857,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT02456857,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03504488,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02922218,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02922218,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06747845,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06747845,TARGETS_BIOMARKER,PARP
BIOTECH_TRIAL:NCT06747845,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06747845,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT06747845,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05012254,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05012254,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05012254,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04626440,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT04626440,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03414684,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03414684,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03414684,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03414684,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02113657,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02113657,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02113657,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06238921,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06238921,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06238921,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02007512,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT05008510,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05008510,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05008510,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT00600249,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT00600249,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02531425,USES_DRUG_TYPE,DNA
BIOTECH_TRIAL:NCT02531425,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03800836,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03800836,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT03800836,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03800836,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03800836,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03499899,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03499899,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03499899,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01969643,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01969643,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03241186,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03241186,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03241186,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03241186,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03330847,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT03330847,TARGETS_BIOMARKER,BRCA1
BIOTECH_TRIAL:NCT03330847,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03330847,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT06682195,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06682195,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06682195,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04537286,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04537286,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04537286,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05749575,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05749575,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT05749575,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05749575,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02528643,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02528643,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06718647,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT06718647,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01898117,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01898117,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01898117,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT01898117,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04013854,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04013854,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04013854,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04013854,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05250336,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT05250336,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT05250336,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03153085,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03153085,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04683679,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04683679,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04683679,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT04683679,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04683679,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02057939,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02057939,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06968988,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06968988,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06968988,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06968988,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04408118,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04408118,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04408118,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04408118,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06261918,USES_DRUG_TYPE,CELLULAR
BIOTECH_TRIAL:NCT06261918,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05916755,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT05916755,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05916755,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT02669771,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT03437941,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT03437941,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04148911,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04148911,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT04148911,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04148911,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04148911,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03377023,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03377023,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03377023,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03377023,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01562275,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT01562275,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06631092,USES_DRUG_TYPE,DNA
BIOTECH_TRIAL:NCT06631092,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03577743,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03577743,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03577743,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06889688,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06889688,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06889688,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04373031,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04373031,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04373031,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04373031,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06126731,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT06126731,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02737475,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02737475,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02737475,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02737475,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02971761,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02971761,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02971761,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02971761,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05386524,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05386524,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05386524,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06081244,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06081244,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06081244,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06081244,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04265872,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04265872,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04265872,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04265872,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06393374,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06393374,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06393374,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06393374,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06618014,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06618014,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06618014,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05498597,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05498597,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03283046,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03283046,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03283046,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03283046,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05957939,USES_DRUG_TYPE,HORMONAL
BIOTECH_TRIAL:NCT05957939,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02403271,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02403271,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02403271,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02117362,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02117362,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02117362,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03369223,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03369223,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03369223,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04674306,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04674306,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04674306,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04674306,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06568692,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT06568692,TARGETS_BIOMARKER,PARP
BIOTECH_TRIAL:NCT06568692,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06165900,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06165900,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06165900,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05675579,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05675579,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05675579,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05675579,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03203304,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03203304,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03203304,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03203304,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03393416,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03393416,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02120469,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT02120469,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02120469,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT02068196,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02068196,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02068196,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01201265,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01201265,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01201265,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01208480,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01208480,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01208480,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04879888,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT04879888,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04879888,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06059118,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT06059118,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04794010,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04794010,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04794010,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04794010,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04634747,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT04634747,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT04634747,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04634747,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04634747,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05770531,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05770531,TARGETS_BIOMARKER,TROP2
BIOTECH_TRIAL:NCT05770531,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05770531,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05609903,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05609903,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05609903,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04584112,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04584112,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04584112,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04584112,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02530463,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02530463,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02530463,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02530463,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05076682,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT05076682,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05076682,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT03784040,USES_DRUG_TYPE,VACCINE
BIOTECH_TRIAL:NCT03784040,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03784040,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT03784040,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03784040,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06959537,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06959537,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06959537,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06337084,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06337084,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02543645,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02543645,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT02543645,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02543645,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02543645,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01565837,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01565837,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01565837,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03110588,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT06195618,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT06195618,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06195618,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06067061,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06067061,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06067061,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06067061,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06078670,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06078670,TARGETS_BIOMARKER,PARP
BIOTECH_TRIAL:NCT06078670,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06078670,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04185311,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04185311,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04185311,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT04185311,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04185311,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01902251,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT01902251,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01931163,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT01931163,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01931163,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT03219268,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03219268,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03219268,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06387628,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06387628,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05037825,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT05037825,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05037825,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT04809779,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04809779,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03102320,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03102320,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03102320,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04043195,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04043195,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04043195,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04043195,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03172624,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03172624,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03172624,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03172624,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06104085,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06104085,TARGETS_BIOMARKER,TROP2
BIOTECH_TRIAL:NCT06104085,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06104085,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05680662,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT05680662,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05192798,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05192798,TARGETS_BIOMARKER,VEGF
BIOTECH_TRIAL:NCT05192798,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05192798,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02996825,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02996825,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02996825,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01195298,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01195298,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01195298,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03599453,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT03599453,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03599453,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03599453,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05973864,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05973864,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05973864,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05973864,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05234606,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05234606,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05234606,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06975644,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06975644,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06975644,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04434560,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04434560,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04434560,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04434560,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06342037,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06342037,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06342037,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06342037,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03292172,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03292172,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03292172,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03292172,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05633654,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05633654,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05633654,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05633654,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06581406,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06581406,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06581406,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT06581406,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06581406,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04434040,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04434040,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04434040,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04434040,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02460068,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02460068,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02460068,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02460068,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06793332,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06793332,TARGETS_BIOMARKER,TROP2
BIOTECH_TRIAL:NCT06793332,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06793332,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06993506,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06993506,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT00868634,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT00868634,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT00868634,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04486911,USES_DRUG_TYPE,HORMONAL
BIOTECH_TRIAL:NCT04486911,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04486911,TARGETS_BIOMARKER,CDK4
BIOTECH_TRIAL:NCT04486911,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT03573947,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03573947,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03573947,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03573947,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04595565,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04595565,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04595565,TARGETS_BIOMARKER,CDK4
BIOTECH_TRIAL:NCT04595565,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04595565,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT04595565,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04348916,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT04348916,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05460273,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05460273,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05460273,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03358017,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT03358017,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02368951,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02368951,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05233696,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05233696,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT05233696,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05233696,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03012230,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT03012230,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03012230,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03012230,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02752685,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02752685,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT02752685,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02752685,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02752685,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06637306,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06637306,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06637306,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06637306,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04855929,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04855929,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02663193,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02663193,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06380816,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06380816,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01031446,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT01031446,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT06878625,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06878625,TARGETS_BIOMARKER,TROP2
BIOTECH_TRIAL:NCT06878625,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06878625,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04244552,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04244552,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02983045,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02983045,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02983045,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02983045,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05082610,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05082610,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05082610,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05082610,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06844383,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT06844383,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06844383,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT03775850,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03775850,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03775850,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03775850,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02593175,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02593175,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02593175,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04877821,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04877821,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04877821,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05382286,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05382286,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT05382286,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05382286,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05382286,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06976021,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06976021,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06976021,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06976021,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06084689,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06084689,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06084689,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04676997,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04676997,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04676997,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06851299,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06851299,TARGETS_BIOMARKER,TROP2
BIOTECH_TRIAL:NCT06538896,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06538896,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06538896,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06140576,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06140576,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06140576,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03167619,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03167619,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03167619,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT03167619,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01409187,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT01409187,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01409187,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02768701,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02768701,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02768701,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02567396,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT02567396,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02567396,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT02929576,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02929576,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04441099,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04441099,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05989828,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT05989828,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02918968,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02918968,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT07011823,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT07011823,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT07011823,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT07011823,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT07011823,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04734262,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04734262,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04734262,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02089854,USES_DRUG_TYPE,HORMONAL
BIOTECH_TRIAL:NCT02089854,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03594396,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03594396,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03594396,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT03594396,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03070392,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03070392,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03070392,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03070392,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02437279,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02437279,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02437279,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02437279,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06831955,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT05005273,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05005273,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05005273,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05005273,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04124601,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04124601,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04124601,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04124601,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT00759785,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT00759785,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT00759785,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06771609,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06771609,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT04491942,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT04491942,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05955105,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05955105,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05955105,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03036488,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03036488,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03036488,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03036488,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04745975,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT04745975,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04745975,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT05660083,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT05660083,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT00463788,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT00463788,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT00463788,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02208375,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT02208375,TARGETS_BIOMARKER,PARP
BIOTECH_TRIAL:NCT02208375,TARGETS_BIOMARKER,AKT
BIOTECH_TRIAL:NCT02208375,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02208375,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT02208375,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT05403554,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05403554,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01689870,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01689870,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01689870,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02498613,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT02498613,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02498613,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT06313463,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06313463,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06313463,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06249048,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06249048,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06249048,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06249048,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02509507,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02509507,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02509507,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02509507,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06672120,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT06672120,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02711956,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT05384496,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05384496,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05384496,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05384496,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04712396,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT04712396,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06616987,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06616987,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06616987,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06072196,USES_DRUG_TYPE,HORMONAL
BIOTECH_TRIAL:NCT06072196,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03468985,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT03468985,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03468985,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03468985,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05629585,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05629585,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05629585,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02125084,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02125084,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT06849492,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06849492,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04722718,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04722718,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT04722718,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04722718,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02427581,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT02427581,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02977468,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02977468,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02977468,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02977468,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02401347,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02401347,TARGETS_BIOMARKER,BRCA1
BIOTECH_TRIAL:NCT02401347,TARGETS_BIOMARKER,BRCA2
BIOTECH_TRIAL:NCT02401347,TARGETS_BIOMARKER,PARP
BIOTECH_TRIAL:NCT02401347,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02401347,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT05816655,USES_DRUG_TYPE,HORMONAL
BIOTECH_TRIAL:NCT05816655,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05816655,TARGETS_BIOMARKER,CDK4
BIOTECH_TRIAL:NCT05816655,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT05816655,HAS_DRUG_CLASS,Hormonal therapy
BIOTECH_TRIAL:NCT06829199,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06829199,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06829199,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06829199,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04514484,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT04514484,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04514484,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04514484,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04655365,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT04655365,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06594991,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06594991,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04975451,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04975451,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03544125,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT03544125,TARGETS_BIOMARKER,PARP
BIOTECH_TRIAL:NCT03544125,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03544125,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT03544125,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04907344,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04907344,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04907344,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05451784,USES_DRUG_TYPE,RNA
BIOTECH_TRIAL:NCT05451784,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04025216,USES_DRUG_TYPE,CELLULAR
BIOTECH_TRIAL:NCT04025216,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06885424,USES_DRUG_TYPE,DNA
BIOTECH_TRIAL:NCT06885424,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06448169,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT06448169,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT00894504,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT00894504,TARGETS_BIOMARKER,EGFR
BIOTECH_TRIAL:NCT00894504,TARGETS_BIOMARKER,PTEN
BIOTECH_TRIAL:NCT00894504,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT00894504,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT00894504,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04418219,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT04418219,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04418219,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02890069,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT02890069,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02890069,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT03794596,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03794596,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03794596,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT03794596,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03989362,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03989362,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT03989362,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06963905,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06963905,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT06963905,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06963905,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01911741,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT01911741,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04332653,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04332653,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04332653,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04332653,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03982173,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03982173,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03982173,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02838823,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02838823,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02838823,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04248569,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT04248569,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04248569,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04248569,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03971409,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT03971409,TARGETS_BIOMARKER,TROP2
BIOTECH_TRIAL:NCT03971409,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03971409,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02779855,USES_DRUG_TYPE,VIRAL
BIOTECH_TRIAL:NCT02779855,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01928394,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01928394,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01928394,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT01928394,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03083691,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03083691,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03083691,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT03083691,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03083691,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05136677,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05136677,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05136677,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05136677,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02260531,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02260531,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02260531,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01946165,USES_DRUG_TYPE,HORMONAL
BIOTECH_TRIAL:NCT01946165,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06099769,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT06099769,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06418594,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06418594,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT06418594,TARGETS_BIOMARKER,EGFR
BIOTECH_TRIAL:NCT06418594,TARGETS_BIOMARKER,VEGF
BIOTECH_TRIAL:NCT06418594,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06418594,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02641847,USES_DRUG_TYPE,RNA
BIOTECH_TRIAL:NCT02641847,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03927391,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT03927391,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02740985,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02740985,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02740985,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03207529,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT03207529,TARGETS_BIOMARKER,PTEN
BIOTECH_TRIAL:NCT03207529,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03010176,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03010176,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT03010176,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03010176,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03010176,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03184558,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03184558,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03184558,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03184558,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04628988,USES_DRUG_TYPE,HORMONAL
BIOTECH_TRIAL:NCT04628988,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03674827,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT03674827,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02447003,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02447003,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02447003,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02447003,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03256344,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03256344,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03256344,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03256344,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04282044,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04282044,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04282044,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04282044,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01009983,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01009983,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01009983,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03219775,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03219775,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT03219775,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03219775,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT03219775,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03219775,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02657889,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02657889,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02657889,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT02657889,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02657889,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT00608972,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT00608972,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT00608972,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05492682,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT05492682,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05492682,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05492682,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03196388,USES_DRUG_TYPE,HORMONAL
BIOTECH_TRIAL:NCT03196388,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06991790,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06991790,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06991790,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03435640,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03435640,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03435640,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03435640,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05402722,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06709651,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT06709651,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01116648,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT01116648,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01116648,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT03297593,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03297593,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03297593,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03297593,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02130700,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT06167317,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06167317,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06167317,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05866432,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05866432,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06636981,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06636981,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01250379,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01250379,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01250379,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06471205,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT07046455,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT07046455,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT07046455,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04424641,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04424641,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04635735,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04635735,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03829436,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03829436,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03829436,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03829436,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03915678,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03915678,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03915678,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03354962,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03354962,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03354962,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT03354962,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03354962,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01097642,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01097642,TARGETS_BIOMARKER,EGFR
BIOTECH_TRIAL:NCT01097642,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01097642,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01857193,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT01857193,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01857193,TARGETS_BIOMARKER,CDK4
BIOTECH_TRIAL:NCT01857193,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT01818063,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT01818063,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02630368,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02630368,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02630368,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06798506,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06798506,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03363893,USES_DRUG_TYPE,HORMONAL
BIOTECH_TRIAL:NCT03363893,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03363893,HAS_DRUG_CLASS,Hormonal therapy
BIOTECH_TRIAL:NCT05770102,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05770102,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05770102,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05770102,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04188119,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04188119,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04188119,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT04188119,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05455619,USES_DRUG_TYPE,HORMONAL
BIOTECH_TRIAL:NCT05455619,TARGETS_BIOMARKER,PIK3CA
BIOTECH_TRIAL:NCT05455619,TARGETS_BIOMARKER,AKT
BIOTECH_TRIAL:NCT05455619,TARGETS_BIOMARKER,PTEN
BIOTECH_TRIAL:NCT05455619,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05455619,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT05455619,HAS_DRUG_CLASS,Hormonal therapy
BIOTECH_TRIAL:NCT04574583,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT04574583,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT04574583,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03004183,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03004183,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03004183,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05145907,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05145907,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05145907,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05145907,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT07011654,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT07011654,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT07011654,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03915951,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT03915951,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT03915951,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04129996,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04129996,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04129996,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT00472693,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT00472693,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06833723,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT06833723,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04669899,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT04669899,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03151447,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04585750,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04585750,TARGETS_BIOMARKER,TP53
BIOTECH_TRIAL:NCT04585750,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04585750,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04585750,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02637531,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02637531,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02637531,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02637531,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05498896,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05498896,TARGETS_BIOMARKER,AKT
BIOTECH_TRIAL:NCT05498896,TARGETS_BIOMARKER,PTEN
BIOTECH_TRIAL:NCT05498896,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05498896,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT05498896,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03026166,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03026166,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03026166,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03026166,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03567720,USES_DRUG_TYPE,DNA
BIOTECH_TRIAL:NCT03567720,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03567720,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03567720,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02348320,USES_DRUG_TYPE,DNA
BIOTECH_TRIAL:NCT04949113,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04949113,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04949113,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04949113,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01363206,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01363206,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01363206,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05520723,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05520723,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05520723,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03404960,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03404960,TARGETS_BIOMARKER,PARP
BIOTECH_TRIAL:NCT03404960,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03404960,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT03404960,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03404960,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03396445,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03396445,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03396445,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03396445,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04639245,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04639245,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04639245,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04639245,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02622074,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02622074,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02622074,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02622074,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03970382,USES_DRUG_TYPE,CELLULAR
BIOTECH_TRIAL:NCT03970382,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02917772,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02917772,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02917772,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02917772,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05694364,USES_DRUG_TYPE,CELLULAR
BIOTECH_TRIAL:NCT05694364,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03058289,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT05097248,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05097248,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05097248,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02393794,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02393794,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02393794,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03686124,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03686124,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03686124,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03752723,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03752723,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03752723,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03752723,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT07016399,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT07016399,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT07016399,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT07016399,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06879704,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT06879704,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04475601,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT04475601,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04504669,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04504669,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04504669,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05552001,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05552001,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05552001,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01631552,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01631552,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01631552,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03243331,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03424005,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT03424005,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT03424005,TARGETS_BIOMARKER,PIK3CA
BIOTECH_TRIAL:NCT03424005,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04216472,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT04216472,TARGETS_BIOMARKER,PIK3CA
BIOTECH_TRIAL:NCT04216472,TARGETS_BIOMARKER,PTEN
BIOTECH_TRIAL:NCT03650894,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03650894,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT03650894,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03650894,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05776875,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05776875,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05776875,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05776875,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05382299,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05382299,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT05382299,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05382299,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03125902,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03125902,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT03125902,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03125902,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03125902,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05556200,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05556200,TARGETS_BIOMARKER,EGFR
BIOTECH_TRIAL:NCT05556200,TARGETS_BIOMARKER,VEGF
BIOTECH_TRIAL:NCT05556200,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05556200,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06545331,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06545331,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06545331,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06545331,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02624973,USES_DRUG_TYPE,DNA
BIOTECH_TRIAL:NCT02624973,TARGETS_BIOMARKER,TP53
BIOTECH_TRIAL:NCT02624973,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02624973,HAS_DRUG_CLASS,Hormonal therapy
BIOTECH_TRIAL:NCT02812524,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02812524,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02812524,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01986426,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT01986426,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01986426,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT01986426,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04251533,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT04251533,TARGETS_BIOMARKER,PIK3CA
BIOTECH_TRIAL:NCT04251533,TARGETS_BIOMARKER,PTEN
BIOTECH_TRIAL:NCT04251533,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03408587,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03408587,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02435680,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02435680,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05763992,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT05763992,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04691375,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04691375,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04691375,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04691375,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04134884,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT04134884,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04134884,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT06492005,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT01964924,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT01964924,TARGETS_BIOMARKER,AKT
BIOTECH_TRIAL:NCT01964924,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01964924,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT06225284,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06225284,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03546686,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03546686,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03546686,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT03546686,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03546686,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01848834,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01848834,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT01848834,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01848834,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT01848834,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02900664,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT02900664,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02900664,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03644589,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03644589,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03644589,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03644589,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03197935,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03197935,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT03197935,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03197935,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03197935,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03356860,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03356860,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03356860,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04626635,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04626635,TARGETS_BIOMARKER,EGFR
BIOTECH_TRIAL:NCT04626635,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04626635,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06367088,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06367088,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06367088,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04605146,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04605146,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04605146,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04605146,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03589339,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT05830539,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT03121352,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03121352,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03121352,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03121352,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01534052,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02982486,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02982486,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02982486,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02982486,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01319539,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT01319539,TARGETS_BIOMARKER,AKT
BIOTECH_TRIAL:NCT01319539,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT03634150,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT03634150,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02350764,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02350764,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02350764,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03328364,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT03328364,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03026140,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03026140,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03026140,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT03026140,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03026140,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02708680,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02708680,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02708680,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02708680,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06889610,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06889610,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06889610,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06712927,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06712927,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06712927,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01950195,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01950195,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01950195,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04177108,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04177108,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04177108,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05491226,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05491226,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05491226,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05491226,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04176848,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04176848,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02706392,USES_DRUG_TYPE,CELLULAR
BIOTECH_TRIAL:NCT02706392,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01750073,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01750073,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01750073,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03117309,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03117309,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03117309,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03117309,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03295565,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT03295565,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03473691,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03473691,TARGETS_BIOMARKER,MYC
BIOTECH_TRIAL:NCT03473691,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03473691,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05460702,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT05460702,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05460702,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT04620200,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04620200,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04620200,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04620200,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02628132,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02628132,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT02628132,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02628132,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT07040644,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT07040644,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT07040644,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT07040644,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05673200,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05673200,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT05673200,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05673200,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05673200,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03756298,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03756298,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT03756298,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03756298,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03756298,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05760378,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05760378,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05999149,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05999149,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05999149,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04254107,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04254107,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04254107,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04561362,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04561362,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04561362,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04561362,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT00479674,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT00479674,TARGETS_BIOMARKER,VEGF
BIOTECH_TRIAL:NCT00479674,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT00479674,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02977052,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02977052,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02977052,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02977052,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03579472,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT04755868,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT04755868,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04755868,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT04368468,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT04368468,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04368468,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT02731729,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02731729,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02731729,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02731729,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05422794,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05422794,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05422794,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05422794,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03520491,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03520491,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03520491,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01981707,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT01981707,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04472767,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04472767,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04472767,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04472767,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05455658,USES_DRUG_TYPE,DNA
BIOTECH_TRIAL:NCT05455658,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05821686,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT05821686,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05374512,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT05374512,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT05374512,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05374512,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04335006,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04335006,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04335006,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04225117,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04225117,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04225117,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04225117,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06431633,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06431633,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06431633,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03326258,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03326258,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03326258,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT07015853,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT07015853,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT07015853,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT07015853,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04145232,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT04145232,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04145232,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT03641560,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT03641560,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06492759,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06492759,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT06492759,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06492759,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06492759,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03564197,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03564197,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT03564197,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03564197,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03564197,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03739931,USES_DRUG_TYPE,RNA
BIOTECH_TRIAL:NCT03739931,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03739931,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT06794775,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06794775,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06794775,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06794775,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04711109,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04711109,TARGETS_BIOMARKER,BRCA1
BIOTECH_TRIAL:NCT04711109,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04711109,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03281954,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03281954,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03281954,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03281954,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06401005,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06401005,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06401005,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02642913,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02642913,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02863900,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT02863900,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02863900,HAS_DRUG_CLASS,Hormonal therapy
BIOTECH_TRIAL:NCT04191135,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04191135,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04191135,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT04191135,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04191135,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04481763,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04481763,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04481763,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04557449,USES_DRUG_TYPE,HORMONAL
BIOTECH_TRIAL:NCT04557449,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04557449,HAS_DRUG_CLASS,Hormonal therapy
BIOTECH_TRIAL:NCT03918278,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03918278,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03918278,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03918278,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05161325,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05161325,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05161325,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05161325,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02826434,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT02826434,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT02826434,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02826434,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03983954,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03983954,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01688492,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01688492,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01688492,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06404736,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06404736,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03044730,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03044730,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03044730,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03044730,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02288247,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02288247,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03218826,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT03218826,TARGETS_BIOMARKER,PTEN
BIOTECH_TRIAL:NCT03218826,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT04313075,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04313075,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04313075,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01377389,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01377389,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01377389,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT07018427,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT07018427,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03168880,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03168880,TARGETS_BIOMARKER,PARP
BIOTECH_TRIAL:NCT03168880,TARGETS_BIOMARKER,EGFR
BIOTECH_TRIAL:NCT03168880,TARGETS_BIOMARKER,VEGF
BIOTECH_TRIAL:NCT03168880,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03168880,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03362060,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03362060,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03362060,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03362060,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04725331,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04725331,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04725331,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05698238,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05698238,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03293784,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03293784,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT03293784,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03293784,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02316457,USES_DRUG_TYPE,RNA
BIOTECH_TRIAL:NCT02316457,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01777932,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01777932,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01777932,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05078047,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT05078047,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT05078047,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05081193,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT05081193,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05208762,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05208762,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05208762,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05208762,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02380313,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02380313,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04739670,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04739670,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04739670,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT04739670,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04739670,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02457910,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02457910,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02457910,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT06245889,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06245889,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06245889,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06245889,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02668770,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02668770,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02668770,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06125080,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06125080,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06125080,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03285321,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03285321,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03285321,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06176261,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06176261,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06176261,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03106077,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03106077,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03106077,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04556773,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04556773,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04556773,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06880029,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06880029,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06880029,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06497322,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT06497322,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03911973,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT03911973,TARGETS_BIOMARKER,BRCA1
BIOTECH_TRIAL:NCT03911973,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03911973,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT04460456,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT05681728,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05681728,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05681728,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03891953,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT03891953,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT03891953,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02531932,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02531932,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02531932,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT06257264,USES_DRUG_TYPE,HORMONAL
BIOTECH_TRIAL:NCT06257264,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06257264,TARGETS_BIOMARKER,CDK4
BIOTECH_TRIAL:NCT06257264,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT06257264,HAS_DRUG_CLASS,Hormonal therapy
BIOTECH_TRIAL:NCT06974604,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06974604,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06974604,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05475678,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05475678,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05475678,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04894994,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04894994,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT04894994,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04894994,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06377111,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT06377111,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04180371,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04180371,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04180371,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04180371,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02124668,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02124668,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01664923,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT01664923,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT00749502,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT00749502,TARGETS_BIOMARKER,PARP
BIOTECH_TRIAL:NCT00749502,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06817525,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06817525,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06817525,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04927884,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04927884,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT04927884,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06175390,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06175390,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06175390,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06175390,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03720431,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03720431,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03720431,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03720431,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04258150,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT04258150,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04258150,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04258150,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06976944,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06976944,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT06976944,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06976944,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT06976944,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06976944,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04081389,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT04081389,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06840483,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06840483,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05148546,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05148546,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05148546,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05148546,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06151418,USES_DRUG_TYPE,HORMONAL
BIOTECH_TRIAL:NCT06151418,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02659540,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02659540,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02659540,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02659540,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01104259,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT01104259,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04454437,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04454437,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04454437,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06966700,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06966700,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06966700,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06966700,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04709276,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04709276,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04709276,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04709276,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03667716,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03667716,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03667716,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03667716,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05544929,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05544929,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05544929,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05544929,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06977542,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06977542,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06977542,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01272141,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT01272141,TARGETS_BIOMARKER,EGFR
BIOTECH_TRIAL:NCT01272141,TARGETS_BIOMARKER,MYC
BIOTECH_TRIAL:NCT01272141,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01272141,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT03225547,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03225547,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03225547,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03225547,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04250246,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04250246,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT04250246,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04250246,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04250246,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03850795,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT03850795,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04521621,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04521621,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04521621,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04521621,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02288936,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02288936,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06418139,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06418139,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06418139,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT06418139,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06418139,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02926196,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02926196,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT02926196,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02926196,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05537740,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05537740,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT05537740,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05537740,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05537740,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT00640861,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT00640861,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04348747,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04348747,TARGETS_BIOMARKER,HER3
BIOTECH_TRIAL:NCT04348747,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT04348747,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04348747,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03692338,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03692338,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03692338,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03692338,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06827613,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06827613,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06827613,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06681064,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT06681064,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06279364,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT06279364,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT06279364,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01695057,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT05194072,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05194072,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05194072,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05194072,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02922283,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT02922283,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02922283,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT02922283,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02922283,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03206203,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03206203,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03206203,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03206203,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01838200,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01838200,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01838200,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05223673,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05223673,TARGETS_BIOMARKER,EGFR
BIOTECH_TRIAL:NCT05223673,TARGETS_BIOMARKER,VEGF
BIOTECH_TRIAL:NCT05223673,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05223673,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06202313,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06202313,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06202313,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06270706,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06270706,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06270706,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06270706,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03347123,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03347123,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03347123,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03347123,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03190265,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03190265,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03190265,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03190265,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05303038,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05303038,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02815033,USES_DRUG_TYPE,TARGETED_BIOLOGIC_SMALL_MOLECULE
BIOTECH_TRIAL:NCT02815033,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01939054,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT01939054,TARGETS_BIOMARKER,EGFR
BIOTECH_TRIAL:NCT01939054,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01939054,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03740893,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT03740893,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT03740893,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03310957,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03310957,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03310957,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT03310957,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06135714,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06135714,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT06135714,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06135714,TARGETS_BIOMARKER,CDK4
BIOTECH_TRIAL:NCT06135714,INVOLVES_PATHWAY,Immune checkpoint
BIOTECH_TRIAL:NCT06135714,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT06135714,HAS_DRUG_CLASS,Kinase inhibitor
BIOTECH_TRIAL:NCT06135714,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT01234532,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT01234532,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT01234532,HAS_DRUG_CLASS,Hormonal therapy
BIOTECH_TRIAL:NCT02020070,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02020070,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02020070,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06402435,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06402435,TARGETS_BIOMARKER,VEGF
BIOTECH_TRIAL:NCT06402435,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06402435,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT06533384,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06533384,TARGETS_BIOMARKER,BRCA1
BIOTECH_TRIAL:NCT06533384,TARGETS_BIOMARKER,PARP
BIOTECH_TRIAL:NCT06533384,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06533384,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05266937,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT05266937,TARGETS_BIOMARKER,PD-L1
BIOTECH_TRIAL:NCT05266937,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05266937,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05266937,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05404321,USES_DRUG_TYPE,CELLULAR
BIOTECH_TRIAL:NCT05404321,TARGETS_BIOMARKER,BRCA1
BIOTECH_TRIAL:NCT05404321,TARGETS_BIOMARKER,PARP
BIOTECH_TRIAL:NCT05404321,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06451497,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT06451497,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT06451497,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT06451497,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05891197,USES_DRUG_TYPE,CELLULAR
BIOTECH_TRIAL:NCT05891197,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04303988,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04303988,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04303988,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03667612,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT03667612,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03808441,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT03808441,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04850755,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04850755,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT04850755,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT03838367,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03838367,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03838367,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT00691379,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT00691379,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT00691379,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04039230,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT04039230,TARGETS_BIOMARKER,PARP
BIOTECH_TRIAL:NCT04039230,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT04039230,HAS_DRUG_CLASS,PARP inhibitor
BIOTECH_TRIAL:NCT04039230,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05093387,USES_DRUG_TYPE,DNA
BIOTECH_TRIAL:NCT05093387,TARGETS_BIOMARKER,TP53
BIOTECH_TRIAL:NCT05093387,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT05093387,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT05093387,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT02904226,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT02904226,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT02904226,HAS_DRUG_CLASS,Checkpoint inhibitor
BIOTECH_TRIAL:NCT02904226,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT00861705,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT00861705,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT00861705,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT04020575,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT04020575,TARGETS_BIOMARKER,AR
BIOTECH_TRIAL:NCT03291938,USES_DRUG_TYPE,PROTEIN
BIOTECH_TRIAL:NCT03742102,USES_DRUG_TYPE,ANTIBODY
BIOTECH_TRIAL:NCT03742102,HAS_DRUG_CLASS,Antibody
BIOTECH_TRIAL:NCT05967533,USES_DRUG_TYPE,IMMUNO
BIOTECH_TRIAL:NCT05967533,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05849298,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05849298,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT00499603,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT00499603,TARGETS_BIOMARKER,AKT
CHEMICAL_TRIAL:NCT00499603,TARGETS_BIOMARKER,PTEN
CHEMICAL_TRIAL:NCT00499603,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT00499603,HAS_DRUG_CLASS,Kinase inhibitor
CHEMICAL_TRIAL:NCT01173497,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01173497,TARGETS_BIOMARKER,PARP
CHEMICAL_TRIAL:NCT01173497,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06710197,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06710197,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02489448,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02489448,TARGETS_BIOMARKER,PD-L1
CHEMICAL_TRIAL:NCT02489448,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01732276,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01732276,TARGETS_BIOMARKER,EGFR
CHEMICAL_TRIAL:NCT01732276,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05420467,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05420467,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05806060,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05806060,TARGETS_BIOMARKER,EGFR
CHEMICAL_TRIAL:NCT05806060,TARGETS_BIOMARKER,VEGF
CHEMICAL_TRIAL:NCT04289935,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04289935,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06894511,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06894511,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05490472,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05490472,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04849364,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04849364,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05810870,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05810870,TARGETS_BIOMARKER,PIK3CA
CHEMICAL_TRIAL:NCT05810870,TARGETS_BIOMARKER,PTEN
CHEMICAL_TRIAL:NCT05810870,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04664972,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04664972,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01752686,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01752686,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02352025,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02352025,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01112826,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01112826,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT00546364,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05768932,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05768932,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02506556,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02506556,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02506556,HAS_DRUG_CLASS,Kinase inhibitor
CHEMICAL_TRIAL:NCT05461690,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05461690,TARGETS_BIOMARKER,PARP
CHEMICAL_TRIAL:NCT05461690,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05461690,INVOLVES_PATHWAY,DNA repair
CHEMICAL_TRIAL:NCT05461690,HAS_DRUG_CLASS,PARP inhibitor
CHEMICAL_TRIAL:NCT02595905,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02595905,TARGETS_BIOMARKER,PARP
CHEMICAL_TRIAL:NCT02595905,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04296175,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04296175,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01347866,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01347866,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01347866,HAS_DRUG_CLASS,Kinase inhibitor
CHEMICAL_TRIAL:NCT04807192,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04807192,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT00887575,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT00887575,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03981705,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03981705,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02476955,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02476955,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04149444,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04149444,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04362462,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04362462,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01378533,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01378533,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03789851,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03789851,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05071911,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05071911,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06385990,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06385990,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02365831,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02365831,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01251874,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01251874,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06787339,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06787339,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05019690,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05019690,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03387085,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03387085,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02978716,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02978716,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02027376,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02027376,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06684054,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06684054,TARGETS_BIOMARKER,MYC
CHEMICAL_TRIAL:NCT06684054,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01306032,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01306032,TARGETS_BIOMARKER,BRCA1
CHEMICAL_TRIAL:NCT01306032,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04468113,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04468113,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01969032,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01969032,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03411161,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03411161,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03164863,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03164863,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02187991,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02187991,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT00707707,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT00707707,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01238952,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01238952,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06281210,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06281210,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05242874,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04835597,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04835597,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04803539,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04803539,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05058183,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05058183,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04304352,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04304352,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02247037,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06396754,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06396754,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT00542191,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT00542191,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01779479,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01779479,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05390476,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02685657,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02685657,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01207102,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01207102,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT07045311,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT07045311,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04301739,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04301739,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06799065,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06799065,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02161679,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02161679,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02856867,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02856867,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03304756,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03304756,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06767527,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06767527,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06468098,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06468098,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05244993,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05244993,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05747313,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05747313,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04365790,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04365790,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02032277,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02032277,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03855358,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03855358,TARGETS_BIOMARKER,PD-L1
CHEMICAL_TRIAL:NCT03855358,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT00813956,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT00813956,TARGETS_BIOMARKER,PARP
CHEMICAL_TRIAL:NCT00813956,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT00739063,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT00739063,TARGETS_BIOMARKER,EGFR
CHEMICAL_TRIAL:NCT00739063,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04137653,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04137653,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT00491816,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT00491816,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT00532727,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT00532727,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04067102,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04067102,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04836156,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04836156,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02595138,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02595138,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06230185,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06230185,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02474173,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02474173,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06577987,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04333706,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04333706,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04333706,HAS_DRUG_CLASS,Antibody
CHEMICAL_TRIAL:NCT02358200,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02358200,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02672475,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02672475,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02263495,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02263495,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02448576,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02448576,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03457779,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03457779,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02580448,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02580448,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03012477,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03012477,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05067530,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05067530,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05445050,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05445050,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01698281,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01698281,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03154749,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03154749,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01910870,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03201861,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03201861,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01138085,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01138085,TARGETS_BIOMARKER,AKT
CHEMICAL_TRIAL:NCT01138085,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01138085,HAS_DRUG_CLASS,Kinase inhibitor
CHEMICAL_TRIAL:NCT02276443,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02276443,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04452370,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04452370,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06685796,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06685796,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02637375,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02637375,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02607215,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT00031681,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT00031681,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05111561,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05111561,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06635980,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06635980,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06235931,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06235931,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06235931,TARGETS_BIOMARKER,CDK4
CHEMICAL_TRIAL:NCT06235931,HAS_DRUG_CLASS,Kinase inhibitor
CHEMICAL_TRIAL:NCT07021261,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT07021261,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01939418,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01939418,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03920488,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03920488,TARGETS_BIOMARKER,PARP
CHEMICAL_TRIAL:NCT03920488,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04159142,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04159142,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05068141,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05068141,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06498154,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT00938652,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT00938652,TARGETS_BIOMARKER,PARP
CHEMICAL_TRIAL:NCT00938652,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02802423,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02802423,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01891227,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01891227,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01165385,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01165385,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06268327,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06268327,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03932526,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03932526,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02379585,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04762901,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04762901,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04762901,HAS_DRUG_CLASS,PARP inhibitor
CHEMICAL_TRIAL:NCT00630032,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT00630032,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06950671,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06950671,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04297267,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04297267,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06441240,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06441240,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04909554,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04909554,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01074970,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01074970,TARGETS_BIOMARKER,BRCA1
CHEMICAL_TRIAL:NCT01074970,TARGETS_BIOMARKER,PARP
CHEMICAL_TRIAL:NCT01074970,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02012634,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02012634,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04664829,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04664829,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05198843,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05198843,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05300958,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05300958,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04224922,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04224922,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06419621,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06419621,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02679040,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02679040,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03750240,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03750240,TARGETS_BIOMARKER,MYC
CHEMICAL_TRIAL:NCT03750240,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01075100,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01075100,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05333874,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05333874,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02615457,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02615457,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02792114,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02792114,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04138719,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04138719,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04502680,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04502680,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT00789581,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT00789581,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05918133,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01276769,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01276769,TARGETS_BIOMARKER,BRCA1
CHEMICAL_TRIAL:NCT01276769,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT00601159,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT00601159,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05909332,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05909332,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04001569,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04001569,TARGETS_BIOMARKER,PTEN
CHEMICAL_TRIAL:NCT04001569,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04001569,HAS_DRUG_CLASS,Kinase inhibitor
CHEMICAL_TRIAL:NCT04582955,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04582955,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02897050,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02897050,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03076372,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03076372,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02000882,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02000882,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05834582,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05834582,TARGETS_BIOMARKER,PARP
CHEMICAL_TRIAL:NCT05834582,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06931769,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06931769,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06590558,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06590558,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03358004,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03358004,TARGETS_BIOMARKER,BRCA1
CHEMICAL_TRIAL:NCT03358004,TARGETS_BIOMARKER,BRCA2
CHEMICAL_TRIAL:NCT03358004,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03358004,INVOLVES_PATHWAY,DNA repair
CHEMICAL_TRIAL:NCT03554109,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03554109,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06143553,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06143553,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01216111,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01216111,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03057600,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03057600,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02001519,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02001519,TARGETS_BIOMARKER,MYC
CHEMICAL_TRIAL:NCT06355024,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06355024,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03756090,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02041338,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02041338,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03805399,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03805399,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02762981,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02762981,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02422498,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02422498,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04135586,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04135586,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01421472,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01421472,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03055312,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03055312,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03876886,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03876886,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01662128,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01662128,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02688803,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02688803,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02876302,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02876302,TARGETS_BIOMARKER,MYC
CHEMICAL_TRIAL:NCT02876302,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT00603408,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT00603408,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06154109,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06154109,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05636644,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05636644,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04193059,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04193059,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04248998,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04248998,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05555706,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05555706,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05550415,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05550415,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT00022516,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT00022516,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03193853,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02441933,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02441933,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03609671,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03609671,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01928680,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05582499,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05582499,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02370238,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02370238,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05570253,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05570253,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02694224,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02694224,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05020860,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05020860,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06382142,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06382142,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04083963,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04083963,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01617668,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01617668,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03876951,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01738438,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01738438,TARGETS_BIOMARKER,EGFR
CHEMICAL_TRIAL:NCT01738438,TARGETS_BIOMARKER,VEGF
CHEMICAL_TRIAL:NCT01738438,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06833502,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06833502,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01618136,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01618136,TARGETS_BIOMARKER,PARP
CHEMICAL_TRIAL:NCT01618136,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03671044,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03671044,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02595372,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02595372,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03002103,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03002103,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04365803,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04365803,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02950259,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02950259,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03444025,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03444025,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05089643,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05089643,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03580395,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03580395,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01525966,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01525966,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06309290,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06309290,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05949021,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05949021,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT00540358,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT00540358,TARGETS_BIOMARKER,PARP
CHEMICAL_TRIAL:NCT00540358,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05420454,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05420454,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02124902,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02124902,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01642771,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01642771,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01333423,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01333423,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04395989,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04395989,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01606982,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01606982,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06782698,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06782698,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03872388,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03872388,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06476119,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06476119,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02353988,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02353988,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03301350,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03301350,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03601897,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03601897,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05227664,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05227664,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06220214,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06220214,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02834403,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02834403,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04993625,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04993625,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01528826,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02993094,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02993094,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05336721,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05336721,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02521363,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02521363,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05314114,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05314114,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06190600,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06190600,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01674842,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01674842,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01091454,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01091454,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05862610,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05862610,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04192903,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01204125,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01204125,TARGETS_BIOMARKER,PARP
CHEMICAL_TRIAL:NCT01204125,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01155453,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01155453,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01155453,HAS_DRUG_CLASS,Kinase inhibitor
CHEMICAL_TRIAL:NCT01147016,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01147016,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01289353,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01289353,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01150513,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01150513,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02284581,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02284581,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03539965,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03539965,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01045304,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01045304,TARGETS_BIOMARKER,PARP
CHEMICAL_TRIAL:NCT01045304,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05169853,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05169853,TARGETS_BIOMARKER,PD-L1
CHEMICAL_TRIAL:NCT05169853,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06355037,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06355037,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04947189,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04947189,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06085274,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06085274,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03654547,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03654547,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01929941,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01929941,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03709446,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03709446,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02788981,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02788981,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01876251,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01876251,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03383679,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03383679,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04549584,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04549584,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06008275,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04405505,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04405505,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05466760,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05466760,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02315196,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02315196,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT00516724,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT00516724,TARGETS_BIOMARKER,PARP
CHEMICAL_TRIAL:NCT00516724,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01920061,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01920061,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01920061,HAS_DRUG_CLASS,Kinase inhibitor
CHEMICAL_TRIAL:NCT02850302,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02850302,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT00674206,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03717415,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03717415,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03650738,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03650738,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05495295,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05495295,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02833766,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02833766,TARGETS_BIOMARKER,EGFR
CHEMICAL_TRIAL:NCT02833766,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06744465,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06744465,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01287624,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01287624,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03911453,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03911453,TARGETS_BIOMARKER,PD-L1
CHEMICAL_TRIAL:NCT03911453,TARGETS_BIOMARKER,PARP
CHEMICAL_TRIAL:NCT03911453,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01232062,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01232062,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03812393,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03812393,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04706962,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04706962,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01167192,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01167192,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01167192,HAS_DRUG_CLASS,Hormonal therapy
CHEMICAL_TRIAL:NCT01930292,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01930292,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01445418,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01445418,TARGETS_BIOMARKER,BRCA1
CHEMICAL_TRIAL:NCT01445418,TARGETS_BIOMARKER,BRCA2
CHEMICAL_TRIAL:NCT01445418,TARGETS_BIOMARKER,PARP
CHEMICAL_TRIAL:NCT01445418,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT00912444,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT00912444,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05435352,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05435352,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02338531,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02338531,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02445391,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02445391,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01815242,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01815242,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01918306,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01918306,HAS_DRUG_CLASS,Kinase inhibitor
CHEMICAL_TRIAL:NCT01130259,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01130259,TARGETS_BIOMARKER,PARP
CHEMICAL_TRIAL:NCT01130259,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04517292,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04131881,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04131881,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03719326,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03719326,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT00998036,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT00998036,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01401959,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01401959,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05953909,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05953909,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03733119,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03733119,TARGETS_BIOMARKER,AKT
CHEMICAL_TRIAL:NCT03733119,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03733119,HAS_DRUG_CLASS,Kinase inhibitor
CHEMICAL_TRIAL:NCT02203513,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02203513,TARGETS_BIOMARKER,BRCA1
CHEMICAL_TRIAL:NCT02203513,TARGETS_BIOMARKER,BRCA2
CHEMICAL_TRIAL:NCT02203513,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01276496,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01276496,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT00448305,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03907800,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03907800,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04609215,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04609215,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01292083,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03586297,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03586297,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01363232,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01363232,TARGETS_BIOMARKER,EGFR
CHEMICAL_TRIAL:NCT01363232,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01363232,HAS_DRUG_CLASS,Kinase inhibitor
CHEMICAL_TRIAL:NCT03518242,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03518242,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05383196,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05383196,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04045522,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04045522,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02413320,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02413320,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03775928,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03775928,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02720185,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02720185,TARGETS_BIOMARKER,EGFR
CHEMICAL_TRIAL:NCT02720185,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02488967,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02488967,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01395056,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01395056,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02225470,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02225470,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01276899,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01276899,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06224387,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06224387,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03345485,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03345485,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01672671,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01672671,TARGETS_BIOMARKER,BRCA1
CHEMICAL_TRIAL:NCT01672671,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01672671,INVOLVES_PATHWAY,DNA repair
CHEMICAL_TRIAL:NCT02580747,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02580747,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01560663,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01560663,TARGETS_BIOMARKER,BRCA1
CHEMICAL_TRIAL:NCT01560663,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01560663,INVOLVES_PATHWAY,DNA repair
CHEMICAL_TRIAL:NCT03978663,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03978663,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03735082,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03735082,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01333137,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01333137,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01333137,HAS_DRUG_CLASS,Kinase inhibitor
CHEMICAL_TRIAL:NCT05296564,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05296564,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03328494,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03328494,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01216124,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01216124,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01434420,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01434420,TARGETS_BIOMARKER,BRCA1
CHEMICAL_TRIAL:NCT01434420,TARGETS_BIOMARKER,BRCA2
CHEMICAL_TRIAL:NCT01434420,TARGETS_BIOMARKER,PTEN
CHEMICAL_TRIAL:NCT01434420,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03799679,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03799679,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05893368,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05893368,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03254654,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01057069,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01057069,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03872791,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03872791,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02366949,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02366949,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02207335,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02207335,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02125344,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02125344,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04130750,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04130750,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03096054,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03096054,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01612910,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01612910,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06335069,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06335069,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02018458,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02018458,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02341911,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02341911,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT00483223,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT00483223,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06582615,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06582615,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04437160,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04437160,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04722978,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04722978,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01127763,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01127763,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02546934,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02347163,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02347163,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06460298,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04874064,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04874064,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05390710,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04136782,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04136782,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02525068,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02525068,TARGETS_BIOMARKER,AKT
CHEMICAL_TRIAL:NCT02525068,HAS_DRUG_CLASS,Kinase inhibitor
CHEMICAL_TRIAL:NCT01337765,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01337765,TARGETS_BIOMARKER,EGFR
CHEMICAL_TRIAL:NCT01337765,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01337765,HAS_DRUG_CLASS,Kinase inhibitor
CHEMICAL_TRIAL:NCT02744053,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02744053,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01372579,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01372579,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03077776,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03077776,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04677816,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04677816,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT00130533,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT00130533,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01194869,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01194869,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06291064,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06291064,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02934828,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02934828,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06678048,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06678048,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06876636,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06876636,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05086731,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05086731,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06746870,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06746870,TARGETS_BIOMARKER,EGFR
CHEMICAL_TRIAL:NCT06746870,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02455141,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02455141,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01881230,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01881230,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06229392,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06229392,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02157792,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02157792,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06598046,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06598046,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04213898,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04213898,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02041429,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02041429,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT00717951,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT00717951,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04031703,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04031703,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05212454,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05212454,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03822312,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03822312,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05504707,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05504707,TARGETS_BIOMARKER,HER3
CHEMICAL_TRIAL:NCT05504707,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02547987,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02547987,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03997968,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03997968,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05872412,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04799249,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04799249,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT04268693,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04268693,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01910844,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01910844,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT03075462,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT03075462,TARGETS_BIOMARKER,PARP
CHEMICAL_TRIAL:NCT03075462,TARGETS_BIOMARKER,EGFR
CHEMICAL_TRIAL:NCT03075462,TARGETS_BIOMARKER,VEGF
CHEMICAL_TRIAL:NCT03075462,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01953536,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01953536,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT06299202,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT06299202,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01565928,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04768426,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT04768426,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT05750719,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT05750719,TARGETS_BIOMARKER,BRCA1
CHEMICAL_TRIAL:NCT05750719,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02978495,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02978495,TARGETS_BIOMARKER,BRCA1
CHEMICAL_TRIAL:NCT02978495,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT02985658,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT02985658,TARGETS_BIOMARKER,AR
CHEMICAL_TRIAL:NCT01982448,USES_DRUG_TYPE,OTHER
CHEMICAL_TRIAL:NCT01982448,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05692661,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05692661,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06224244,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06224244,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06371989,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06371989,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03808662,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03808662,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06418126,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06418126,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04959474,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04959474,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04061408,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04061408,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03542175,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03542175,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05318274,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05318274,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03165487,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03165487,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01375023,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01375023,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03808337,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03808337,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05132790,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03101683,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03101683,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01818999,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06938724,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06938724,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05528133,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02945579,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02945579,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03809000,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03809000,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01111175,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01111175,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02464774,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02464774,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06182306,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06182306,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03318562,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03318562,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03394027,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03394027,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04101851,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04101851,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04274946,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04274946,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT07018505,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT07018505,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03623945,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03623945,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03958136,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03958136,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04292821,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04292821,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03596073,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03596073,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04241237,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04241237,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04890340,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04890340,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04225858,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03719833,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03719833,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03122444,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03122444,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04510129,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02639832,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02639832,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06039956,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06039956,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04291950,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04291950,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01836640,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01836640,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02455791,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02455791,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06358573,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06358573,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01083641,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01083641,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01984866,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04985357,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04985357,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03941730,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03941730,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02576665,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02576665,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06246786,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06246786,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06246786,INVOLVES_PATHWAY,DNA repair
OTHER_TRIAL:NCT02921152,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02921152,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05062174,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05062174,TARGETS_BIOMARKER,BRCA1
OTHER_TRIAL:NCT05062174,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05935384,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05935384,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06724263,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06724263,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06019052,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06019052,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06225505,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06225505,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03617341,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03617341,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04039893,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04039893,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06958224,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06958224,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01770353,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03480659,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03480659,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06894173,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06894173,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06586047,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06586047,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03746431,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03746431,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04030507,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04030507,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03863457,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03863457,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04118062,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04118062,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06962163,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06962163,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06508216,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06508216,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06617169,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06617169,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT00754312,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT00754312,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03355066,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03355066,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05757232,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05757232,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06328465,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06328465,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04461990,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04461990,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06562192,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06562192,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06247449,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06247449,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03715959,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03715959,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06305962,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06305962,TARGETS_BIOMARKER,PD-L1
OTHER_TRIAL:NCT06305962,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06430411,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06430411,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02813226,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02813226,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04133077,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04133077,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06422455,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06422455,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06087120,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03071757,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03071757,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05114746,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05114746,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03881605,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03881605,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05675085,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05675085,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01042379,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01042379,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01805076,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01805076,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04226222,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04226222,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06369831,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06369831,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06266026,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06266026,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05115474,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05115474,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04450706,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04450706,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02732860,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02732860,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06059469,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06059469,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03303846,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03303846,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03107663,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03107663,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05309655,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05309655,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04320030,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04320030,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01495663,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01495663,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04803084,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04803084,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04905329,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04174391,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04174391,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06505018,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06505018,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02125006,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02125006,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01498536,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01498536,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05842148,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06994377,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06994377,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04669522,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04669522,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04790305,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04790305,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01662284,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01662284,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04520386,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04520386,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT00576654,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT00576654,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02375958,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01619514,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01619514,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03207867,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03207867,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02035813,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02035813,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01913379,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01913379,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05774886,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05774886,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04580485,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04580485,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04548960,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04548960,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02402764,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02402764,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04610528,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04610528,TARGETS_BIOMARKER,HER3
OTHER_TRIAL:NCT04610528,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01693562,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01693562,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02866149,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02866149,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01629615,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01629615,HAS_DRUG_CLASS,Kinase inhibitor
OTHER_TRIAL:NCT05131893,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05131893,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05131893,HAS_DRUG_CLASS,Hormonal therapy
OTHER_TRIAL:NCT05306600,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02454010,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04363164,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04363164,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04158583,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04158583,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05722795,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05722795,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03253575,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03253575,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06840821,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06840821,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06431100,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06431100,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03241173,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03241173,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02266420,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02266420,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05071677,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05071677,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04179396,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04179396,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02926690,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02926690,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05445908,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05445908,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05099068,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05099068,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04320693,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04320693,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03333915,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03333915,TARGETS_BIOMARKER,BRCA1
OTHER_TRIAL:NCT03333915,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02178722,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02178722,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03575065,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03575065,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT00721409,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT00721409,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT00721409,HAS_DRUG_CLASS,Kinase inhibitor
OTHER_TRIAL:NCT06400472,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06400472,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03361800,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03361800,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06465069,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06465069,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04489940,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04489940,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01653561,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01653561,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06150885,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06150885,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02201381,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02201381,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03364400,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03364400,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02819882,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03126110,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02743910,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02743910,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02575781,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02575781,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05107674,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05347134,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05347134,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01901133,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01901133,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02632448,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02632448,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05154201,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05154201,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02807844,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02807844,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04592484,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04592484,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04592484,HAS_DRUG_CLASS,Kinase inhibitor
OTHER_TRIAL:NCT01669252,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01669252,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04915755,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04915755,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04915755,HAS_DRUG_CLASS,PARP inhibitor
OTHER_TRIAL:NCT04152499,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04152499,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04438681,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04438681,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01587703,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01587703,TARGETS_BIOMARKER,MYC
OTHER_TRIAL:NCT01587703,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02635672,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02635672,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04142554,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04142554,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04142554,HAS_DRUG_CLASS,Kinase inhibitor
OTHER_TRIAL:NCT02583542,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02583542,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05464082,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05464082,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02202746,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02202746,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01790932,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01790932,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01790932,HAS_DRUG_CLASS,Kinase inhibitor
OTHER_TRIAL:NCT05276310,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05276310,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02154776,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02154776,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06941857,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06941857,HAS_DRUG_CLASS,Checkpoint inhibitor
OTHER_TRIAL:NCT06941857,HAS_DRUG_CLASS,Antibody
OTHER_TRIAL:NCT06534762,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06534762,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04178460,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04178460,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04178460,HAS_DRUG_CLASS,PARP inhibitor
OTHER_TRIAL:NCT03251313,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04892342,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04892342,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02038699,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03123211,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03123211,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02368691,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02368691,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06189209,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06189209,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06189209,HAS_DRUG_CLASS,Kinase inhibitor
OTHER_TRIAL:NCT05219578,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05868226,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05868226,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04102618,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04102618,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06036121,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06036121,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04596150,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04596150,HAS_DRUG_CLASS,Antibody
OTHER_TRIAL:NCT05565417,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05565417,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06403904,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06403904,TARGETS_BIOMARKER,BRCA1
OTHER_TRIAL:NCT06403904,TARGETS_BIOMARKER,BRCA2
OTHER_TRIAL:NCT06403904,TARGETS_BIOMARKER,PARP
OTHER_TRIAL:NCT06403904,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06162351,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06162351,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01576666,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01576666,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02460224,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02460224,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05677802,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05677802,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03017573,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03017573,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05983094,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05983094,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04980690,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02833233,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02833233,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02833233,HAS_DRUG_CLASS,Checkpoint inhibitor
OTHER_TRIAL:NCT02833233,HAS_DRUG_CLASS,Antibody
OTHER_TRIAL:NCT06646263,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06646263,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05706129,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05706129,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06781983,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06781983,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06365788,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06365788,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06365788,HAS_DRUG_CLASS,Kinase inhibitor
OTHER_TRIAL:NCT02014337,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02014337,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06274268,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06274268,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01884285,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01884285,TARGETS_BIOMARKER,PTEN
OTHER_TRIAL:NCT01884285,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02659631,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02659631,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03340402,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03340402,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04145947,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02302742,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02302742,TARGETS_BIOMARKER,BRCA1
OTHER_TRIAL:NCT02302742,TARGETS_BIOMARKER,BRCA2
OTHER_TRIAL:NCT02302742,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06399757,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06399757,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02950064,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02950064,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02950064,INVOLVES_PATHWAY,DNA repair
OTHER_TRIAL:NCT03267316,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03267316,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01911728,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01911728,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03205176,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03205176,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06014502,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06014502,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04293094,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04293094,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04718675,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04718675,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT00918892,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT00918892,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03295552,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03295552,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03417115,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03417115,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03974204,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03974204,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05272709,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05272709,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04726332,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04726332,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04461600,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04461600,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04461600,INVOLVES_PATHWAY,Notch
OTHER_TRIAL:NCT05586659,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05586659,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01596751,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01596751,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01639248,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01639248,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05783622,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05783622,TARGETS_BIOMARKER,EGFR
OTHER_TRIAL:NCT05783622,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06405295,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06405295,TARGETS_BIOMARKER,BRCA1
OTHER_TRIAL:NCT06405295,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04314401,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04314401,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06768931,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06768931,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01045421,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05059444,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05059444,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06273800,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06273800,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03092934,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03092934,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01251900,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01251900,TARGETS_BIOMARKER,BRCA1
OTHER_TRIAL:NCT01251900,TARGETS_BIOMARKER,BRCA2
OTHER_TRIAL:NCT01251900,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01837602,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01837602,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02698176,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02698176,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02222922,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02222922,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04985253,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04985253,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04111510,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03094169,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03094169,TARGETS_BIOMARKER,EGFR
OTHER_TRIAL:NCT03094169,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04107142,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04107142,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04099277,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04099277,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06825975,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06825975,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01740427,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01740427,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01740427,HAS_DRUG_CLASS,Kinase inhibitor
OTHER_TRIAL:NCT06682793,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06682793,TARGETS_BIOMARKER,EGFR
OTHER_TRIAL:NCT06682793,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05377996,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05377996,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03150810,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03150810,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06526819,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06526819,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05396612,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05396612,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06586957,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06586957,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06586957,HAS_DRUG_CLASS,Kinase inhibitor
OTHER_TRIAL:NCT06533059,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06533059,TARGETS_BIOMARKER,AKT
OTHER_TRIAL:NCT06533059,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06533059,HAS_DRUG_CLASS,Kinase inhibitor
OTHER_TRIAL:NCT01650506,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01650506,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05759949,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05759949,TARGETS_BIOMARKER,PIK3CA
OTHER_TRIAL:NCT05759949,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05759949,HAS_DRUG_CLASS,Kinase inhibitor
OTHER_TRIAL:NCT04169867,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04169867,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04494958,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04494958,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04494958,TARGETS_BIOMARKER,CDK4
OTHER_TRIAL:NCT04494958,HAS_DRUG_CLASS,Kinase inhibitor
OTHER_TRIAL:NCT05889390,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03348098,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04032080,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02535026,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02535026,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05192694,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05192694,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03538028,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03538028,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06299163,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06299163,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05720117,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05720117,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02299635,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02299635,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02299635,INVOLVES_PATHWAY,Notch
OTHER_TRIAL:NCT03244358,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03244358,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05712889,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05712889,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03613181,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03613181,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03674242,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03674242,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05955521,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05955521,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03549000,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03549000,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05099978,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05099978,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT00679783,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT00679783,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06586866,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06586866,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06732323,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04906369,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04906369,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT07012720,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT07012720,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05339685,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05339685,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01456728,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01456728,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06273852,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06273852,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02078752,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02078752,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05097599,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05097599,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02348281,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02348281,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02812875,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02812875,TARGETS_BIOMARKER,PD-L1
OTHER_TRIAL:NCT02812875,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02812875,INVOLVES_PATHWAY,Immune checkpoint
OTHER_TRIAL:NCT04123704,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04123704,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02158507,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02158507,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06657222,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06657222,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05928780,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05928780,TARGETS_BIOMARKER,TROP2
OTHER_TRIAL:NCT05928780,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03861403,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03861403,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03861403,HAS_DRUG_CLASS,Antibody
OTHER_TRIAL:NCT05730010,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05730010,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05302778,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03130439,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03130439,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03130439,HAS_DRUG_CLASS,Kinase inhibitor
OTHER_TRIAL:NCT03154190,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03154190,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01147484,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06700070,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06700070,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04457700,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04457700,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03251378,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03251378,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT00371254,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01837095,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01015521,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01015521,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02449993,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02449993,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03945721,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03945721,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03945721,HAS_DRUG_CLASS,PARP inhibitor
OTHER_TRIAL:NCT06171789,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06171789,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03277352,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02984683,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02984683,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05684965,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05867251,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05867251,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05867251,HAS_DRUG_CLASS,Kinase inhibitor
OTHER_TRIAL:NCT06666517,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06666517,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04068623,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04068623,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01391143,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02719691,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05933265,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05933265,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03993379,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03993379,TARGETS_BIOMARKER,PD-L1
OTHER_TRIAL:NCT02670577,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT00246571,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT00246571,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05238922,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05238922,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05807516,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05807516,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05324436,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05324436,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06833853,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06833853,TARGETS_BIOMARKER,PD-L1
OTHER_TRIAL:NCT06833853,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06938373,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06938373,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02670668,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02670668,TARGETS_BIOMARKER,BRCA1
OTHER_TRIAL:NCT02670668,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05969041,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05969041,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05253053,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05253053,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02129205,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04551885,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04551885,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06238479,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06238479,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01745367,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01745367,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06439771,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06439771,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06764485,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06764485,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05579366,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05579366,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03970967,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03970967,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02854644,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01520389,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01520389,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05902988,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05902988,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT07020117,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT07020117,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05069935,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02003092,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02101385,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02101385,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04540224,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04540224,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01624441,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01624441,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03316794,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03316794,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06449222,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06449222,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04403529,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04266353,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04266353,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06203119,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06203119,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05891171,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05891171,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02393287,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02393287,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT00951054,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04139993,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04139993,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06057636,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06057636,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03945604,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03945604,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02451735,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02451735,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02993068,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02993068,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02605486,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02605486,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04742959,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04742959,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05861687,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05861687,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06274515,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06274515,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03652077,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03652077,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04315233,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04315233,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04315233,TARGETS_BIOMARKER,CDK4
OTHER_TRIAL:NCT04315233,HAS_DRUG_CLASS,Kinase inhibitor
OTHER_TRIAL:NCT05686720,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05686720,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06084481,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06084481,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01514565,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01514565,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06212076,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06212076,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02485119,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02485119,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05620134,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05620134,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05363072,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05363072,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02587689,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02587689,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06309459,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06309459,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01109381,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01109381,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05088395,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05088395,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06878248,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06878248,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT00827567,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT00827567,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01284920,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01284920,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05957042,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05957042,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05957042,INVOLVES_PATHWAY,Immune checkpoint
OTHER_TRIAL:NCT05388435,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05388435,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02806258,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02806258,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01467310,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01467310,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01377363,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01377363,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05438329,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05438329,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01176669,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01176669,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02048059,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02624700,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02624700,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01141530,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01141530,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02362230,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03197805,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03197805,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01957514,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01957514,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06136884,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03992131,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03992131,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03562637,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03562637,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05749588,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05749588,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06154291,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06154291,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT00940498,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT00940498,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06999187,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06999187,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02482311,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02482311,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT05546255,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05546255,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04770207,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01677455,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02599194,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02599194,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01911715,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04606472,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04606472,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06691984,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06691984,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01849250,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05769491,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT05769491,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT00972023,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT00972023,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04119154,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04119154,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT00897728,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT00897728,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04442126,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT04442126,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06337630,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT00817531,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT00817531,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03576131,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02307240,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02307240,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02307240,HAS_DRUG_CLASS,Kinase inhibitor
OTHER_TRIAL:NCT06150664,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT00580112,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT00580112,TARGETS_BIOMARKER,BRCA1
OTHER_TRIAL:NCT00580112,TARGETS_BIOMARKER,BRCA2
OTHER_TRIAL:NCT00580112,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06264921,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06264921,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT06264921,HAS_DRUG_CLASS,Kinase inhibitor
OTHER_TRIAL:NCT06433804,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06433804,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02783300,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02783300,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT04817813,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03090165,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT03090165,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT03090165,HAS_DRUG_CLASS,Kinase inhibitor
OTHER_TRIAL:NCT01351103,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT01351103,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT01351103,INVOLVES_PATHWAY,Wnt
OTHER_TRIAL:NCT07029399,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT07029399,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT07029399,TARGETS_BIOMARKER,CDK4
OTHER_TRIAL:NCT07029399,HAS_DRUG_CLASS,Kinase inhibitor
OTHER_TRIAL:NCT02365662,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02365662,TARGETS_BIOMARKER,EGFR
OTHER_TRIAL:NCT02365662,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02600143,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02600143,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02600143,INVOLVES_PATHWAY,Immune checkpoint
OTHER_TRIAL:NCT06238687,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT06238687,TARGETS_BIOMARKER,AR
OTHER_TRIAL:NCT02723877,USES_DRUG_TYPE,OTHER
OTHER_TRIAL:NCT02723877,TARGETS_BIOMARKER,AR
